Investor
TRV GP IV, LLC
CIK 0001688325 · filed 2026-05-07 · SEC filing
13F book
$266.9M
Positions
2
Largest name
50.0%
Maze Therapeutics, Inc. · MAZE
Est. mark
$25.1M
Price effect on 2 names still held. Flow −$13.3M.
| Name | Ticker | Shares | Value | Weight | Est. mark | Change |
|---|---|---|---|---|---|---|
| Maze Therapeutics, Inc. | MAZE | 4.47M | $133.5M | 50.0% | −$51.8M | Held |
| Tango Therapeutics, Inc. | TNGX | 6.37M | $133.4M | 50.0% | $76.9M | Cut$63.6M |
Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.